Four spine surgeons discuss trends in the use of spine biologics.
The Latest
The global spine biologics market is predicted to exceed more than $2.5 billion by 2022 with a growth rate of 4.4 percent, Finance Wire reports.
The surgery of spines has begun in the late 1800s. It was not systematic until around 1916 when the neurosurgeon Dr. Charles Elsberg published a book mentioning how to perform surgical procedures on the spine and spinal cord for various…
Syracuse Orthopedic Specialists opened a new 40,000-square-foot location in Clay, N.Y., according to Business Journal News Network.
Westchester-based Brain & Spine Surgeons of New York relocated to an expanded space in Harrison, N.Y., according to Westfair Communications.
Bone Therapeutics reported positive interim efficacy results for its Phase I/IIA delayed-union study evaluating ALLOB in 16 patients. The Data and Safety Monitoring Board recommends ending the trial early due the positive data. Due to the DSMB recommendation, Bone Therapeutics…
A new study published in Spine examined the risk factors for early postoperative complications after posterior cervical fusion.
Implanet reported a slight increase in revenue for the first half of 2017.
South Baldwin Regional Medical Center in Foley, Ala., installed the Hana Hip and Knee Arthroplasty Surgery Table, according to Gulf Coast News Today.
Cedars-Sinai selected 10 startups to join its health-tech accelerator class.